Clinical trial
A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media
NCT00276042 · Replidyne, Industry · Completed
Key facts
| NCT number | NCT00276042 |
|---|---|
| Title | A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media |
| Official title | Prospective, Randomized, Investigator-Blind Trial to Evaluate the Bacteriologic Eradication, Safety and Tolerability, and Pharmacokinetics of Different Dosages of Faropenem Medoxomil BID for 10 Days in the Treatment of Acute Otitis Media |
| Lead sponsor | Replidyne, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Otitis Media |
| Intervention type | Drug |
| Interventions | Faropenem Medoxomil |
| Enrollment | 328 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Feb 8, 2008 |
| Countries | Costa Rica, Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: